EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells

Selina Maier, Werner Schroth, Finn Mier, Lucas Matt, Helmut Bischof, Aiden Tamaddon, Darko Stojkov, Lena Birkenfeld, Melanie Cruz Santos, Dominic Gross, Johanna Dahlen, Florian A Büttner und 6 weitere

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2025.111015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Selina Maier und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany; Dr. Margarete Fischer…. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Potassium, Large-Conductance Calcium-Activated Potassium Channel alpha Subunits. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, Robert Bosch Stiftung, Interfaculty Centre for Pharmacogenomics and Pharma Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The voltage- and calcium (Ca2+)-activated potassium (K+) channel of large conductance (BKCa) is aberrantly expressed in various breast cancer (BC) subtypes, including estrogen receptor (ER)-positive tumors. Increased proliferation of BC cells in response to tamoxifen (TAM) and its metabolites (TAM+M) has been shown to rely on the cell's BKCa status. However, the mechanism by which TAM+M impact on BKCa activity to promote malignancy is yet not clear. By examining murine MMTV-PyMT tumor-derived BC cells and human BC cell lines with a genetically encoded K+ ion indicator and electrophysiological recordings, we identified BKCa-dependent intracellular K+ signals and currents provoked by treatment with clinically relevant TAM+M in an ER-independent manner. In line with this, genetical or pharmacological blockade of BKCa significantly diminished the TAM+M-induced modulation of BKCa K+ currents and consequently also the drop of intracellular K+ ions in BC cells. Changes in the K+ balance subsequently triggered intra- and extracellular Ca2+ mobilization, which was in turn stimulated by the TAM+M-BKCa axis. Our results highlight that BKCa "oncochannels" may modulate the response of BC cells to TAM+M. Activation of the TAM+M-BKCa axis causes significant changes in K+ and Ca2+ ion homeostasis, which ultimately contributes to the outcome of endocrine-based BC pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsPotassiumLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsCalciumHumansFemaleAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

4-HydroxytamoxifenBK(Ca,) breast cancerK(+) channelsendoxifenestrogen receptortamoxifen

Substanzen

TamoxifenPotassiumLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsCalciumKCNMA1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Laboratory for Molecular Design and Pharmaceutical Biophysics, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Ger…

Förderung

  • German Research Foundation
  • Robert Bosch Stiftung
  • Interfaculty Centre for Pharmacogenomics and Pharma Research
  • Austrian Science Fund

Zitieren

APA

Maier, S., Schroth, W., Mier, F., Matt, L., Bischof, H., Tamaddon, A., Stojkov, D., Birkenfeld, L., Cruz Santos, M., Gross, D., Dahlen, J., Büttner, F. A., Bonzheim, I., Fend, F., Brauch, H., Boeckler, F. M., Schwab, M., & Lukowski, R. (2026). Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.111015

Vancouver

Maier S, Schroth W, Mier F, Matt L, Bischof H, Tamaddon A, et al. Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.111015

BibTeX
@article{Maier2026,
  author = {Maier, Selina and Schroth, Werner and Mier, Finn and Matt, Lucas and Bischof, Helmut and Tamaddon, Aiden and Stojkov, Darko and Birkenfeld, Lena and Cruz Santos, Melanie and Gross, Dominic and Dahlen, Johanna and Büttner, Florian A and Bonzheim, Irina and Fend, Falko and Brauch, Hiltrud and Boeckler, Frank M and Schwab, Matthias and Lukowski, Robert},
  title = {Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2025.111015}
}
Kostenlos starten →